comparemela.com

Latest Breaking News On - Xyphos biosciences - Page 1 : comparemela.com

Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology

- Leverages Poseida s proprietary allogeneic CAR-T platform to develop innovative convertibleCAR® programs targeting solid tumors - TOKYO and SAN DIEGO, May 1, 2024 /PRNewswire/ Astellas.

Xyphos biosciencesAstellas pharmaKristin yaremaNaoki okamuraAdam pearsonAstellas companyPoseida therapeutics incExchange commissionXyphos biosciences incAreas of interest astellas pharma incAstellas pharma incPoseida therapeuticsChimeric antigen receptorChief strategy officerPrimary focusFocus area approach

Astellas adds to off-the-shelf cell therapy capabilities with Poseida deal

BioPharma

Yoshitsugu shitakaXyphos biosciencesAstellas pharmaPoseida therapeuticsAudentes therapeuticsOcata therapeuticsKelonia therapeuticsScientific officer yoshitsugu shitaka

Poseida Therapeutics Shares Rise 18% After Licensing Deal With Xyphos Biosciences

By Chris Wack Poseida Therapeutics shares were up 18% to $2.86 after the company said it entered into a research collaboration and license agreement with Astellas Pharma s Xyphos Biosciences.

Astellas pharma xyphos biosciencesChris wackAstellas pharmaXyphos biosciencesXypho accelDow jones

Astellas hops into Poseida s car for $50M cell therapy collab

Astellas hops into Poseida s car for $50M cell therapy collab
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Xyphos biosciencesPoseida therapeutics

Poseida Therapeutics Shares Rise 18% After Licensing Deal With Xyphos Biosciences

Poseida Therapeutics Shares Rise 18% After Licensing Deal With Xyphos Biosciences
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

Astellas pharma xyphos biosciencesChris wackDow jones company incAstellas pharmaXyphos biosciencesXypho accelDow jones

vimarsana © 2020. All Rights Reserved.